$0.740
-0.018 (-2.49%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Barinthus Biotherapeutics PLC (BRNS) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting BRNS is Strong buy.
Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.66, while Barinthus Biotherapeutics PLC (BRNS) share price is $—, making it Buy.
Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.64, while Barinthus Biotherapeutics PLC (BRNS) share price is $—, making it Buy.
Technical Analysis for BRNS
AI Technical BRNSAs of 2026-09-19, the technical board for Barinthus Biotherapeutics PLC (BRNS) reads strong buy: 8 indicators are flashing buy, 1 are indicating sell, and 4 are neutral. Price at $0.74 sits below the 5-day moving averages and above the 10-day, 20-day, 60-day and 200-day.
Momentum readings: RSI stands at 60.269, MACD stands at 0.0384 (Buy), Stochastic %K stands at 68.769, Stochastic %D stands at 74.193 and CCI stands at 59.812.
BRNS trades above the 60-day SMA (0.64) and above the 200-day SMA (0.66). Immediate resistance sits at Classic R1 0.82, then R2 0.91. Support sits at Classic S1 0.64, then S2 0.54.
Barinthus Biotherapeutics PLC (BRNS) Support & Resistance Level
Barinthus Biotherapeutics PLC (BRNS) Technical Indicators
2026-09-19
| Name | Value |
|---|---|
| RSI_14 | 60.269 |
| STOCHk_14_3_3 | 68.769 |
| STOCHd_14_3_3 | 74.193 |
| CCI_20 | 59.812 |
| AO_5_34 | 0.107 |
| MOM_10 | 0.137 |
| MACD_12_26_9 | 0.038 |
Barinthus Biotherapeutics PLC (BRNS) Relative Strength Index (RSI_14) is 60.269, creating a Neutral signal.
Barinthus Biotherapeutics PLC (BRNS) Stochastic %K is 68.769, creating a Neutral signal.
Barinthus Biotherapeutics PLC (BRNS) Stochastic %D is 74.193, creating a Neutral signal.
Barinthus Biotherapeutics PLC (BRNS) CCI_20 is 59.812, creating a Neutral signal.
Barinthus Biotherapeutics PLC (BRNS) Awesome Oscillator (AO) is 0.107, creating a Buy signal.
Barinthus Biotherapeutics PLC (BRNS) Momentum (MOM) is 0.137, creating a Buy signal.
Barinthus Biotherapeutics PLC (BRNS) Moving Average Convergence Divergence (MACD) is 0.038, creating a Buy signal.
Barinthus Biotherapeutics PLC (BRNS) Moving Average
2026-09-19
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.745 | Sell |
| MA_10 | 0.727 | Buy |
| MA_20 | 0.663 | Buy |
| MA_60 | 0.639 | Buy |
| MA_200 | 0.658 | Buy |
| MA_250 | 0.720 | Buy |
Barinthus Biotherapeutics PLC (BRNS) 5-Day simple moving average is 0.745, while Barinthus Biotherapeutics PLC (BRNS) share price is $, making it a Sell.
Barinthus Biotherapeutics PLC (BRNS) 10-Day simple moving average is 0.727, while Barinthus Biotherapeutics PLC (BRNS) share price is $, making it a Buy.
Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.663, while Barinthus Biotherapeutics PLC (BRNS) share price is $, making it a Buy.
Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.639, while Barinthus Biotherapeutics PLC (BRNS) share price is $, making it a Buy.
Barinthus Biotherapeutics PLC (BRNS) 200-Day simple moving average is 0.658, while Barinthus Biotherapeutics PLC (BRNS) share price is $, making it a Buy.
Barinthus Biotherapeutics PLC (BRNS) 250-Day simple moving average is 0.720, while Barinthus Biotherapeutics PLC (BRNS) share price is $, making it a Buy.
Related articles
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
- Bitcoin Bear Market 2026: Why BTC Fell Below $70K and How Investors Can Manage Crypto RiskBitcoin is about 45% below its $126K peak as Fed hikes, 5% yields and ETF outflows bite. See how the 2026 bear market compares and how to manage crypto risk.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.